Your session is about to expire
← Back to Search
Multiple Interventions for Orthostatic Intolerance
Study Summary
This trial is testing different medications to see which one is best at controlling heart rate and improving symptoms of orthostatic intolerance.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am not taking any medication that could worsen a fast heartbeat.I have a long-term serious illness like cancer or heart disease.I have had symptoms for over 6 months when standing up.
- Group 1: 1
- Group 2: 2
- Group 3: 3
- Group 4: 4
- Group 5: 5
- Group 6: 6
- Group 7: 7
- Group 8: 8
- Group 9: 9
- Group 10: 10
- Group 11: 11
- Group 12: 12
- Group 13: 13
- Group 14: 14
- Group 15: 15
- Group 16: 16
- Group 17: 17
- Group 18: 18
- Group 19: 19
- Group 20: Abdominal Binder
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the requirements to qualify for participation in this research?
"This trial is designed for people who suffer from tachycardia and are between 18-70 years old. In total, the researchers need 150 participants."
Are geriatric patients being accepted into this trial?
"According to the information available, people aged 18-70 are eligible to apply for this clinical trial. There are 57 similar studies for those under 18 and 230 for patients over 65."
Is this study enrolling new participants at this time?
"This trial is not currently active. The last update to the listing was on September 12th, 2022. There are 132 other trials for tachycardia and 174 studies involving Breathing Devices that are actively recruiting patients right now."
What sorts of respiratory problems does this Breathing Device help with?
"bursitis is most commonly treated with Breathing Device. Breathing Device can also be useful for treating other conditions like Alzheimer's disease, migraines, dementia, and vascular conditions."
How many individuals are allowed to join this experiment?
"Unfortunately, this specific trial is not currently seeking patients. However, there are 132 other trials related to tachycardia and 174 studies involving Breathing Devices that are actively recruiting participants."
Are there other instances of research being done with this Breathing Device?
"There are 174 live clinical trials testing Breathing Devices, with 42 of those in Phase 3. Geneva, Illinois is one location where these devices are being tested, but there are 1,510 total locations for this type of trial."
Share this study with friends
Copy Link
Messenger